Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Commencement of Ossigel clinical trials

Jan. 22, 1998

Yamasa presents novel xanthine oxidase inhibitors

Jan. 22, 1998

Antiprogestational agents with reduced antiglucocorticoid activity claimed by HHS

Jan. 21, 1998

Duphar presents new vitamin D analogues

Jan. 21, 1998

BMS claims new beta3-adrenoceptor agonists

Jan. 21, 1998

BioTime lays groundwork for Japanese licensing of Hextend

Jan. 20, 1998

Filgrastim reduces neutropenia and morbidity associated with AML treatment

Jan. 20, 1998

Raloxifene launched in U.S.

Jan. 19, 1998

Lilly reports new benzothiophenes for gynecological and other disorders

Jan. 19, 1998

Merck subsidiary and Autogen collaborate on obesity research

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...